Lenalidomide来那度胺盐酸盐,1243329-97

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Lenalidomide hydrochloride

CAS No. : 1243329-97-6

MCE 国际站：Lenalidomide hydrochloride

产品活性：Lenalidomide hydrochloride (CC-5013 hydrochloride) 是 Thalidomide 的衍生物，也是一种具有口服活性免疫调节剂，以分子胶的方式作用。Lenalidomide hydrochloride (CC-5013 hydrochloride) 是一种泛素 E3 连接酶 cereblon (CRBN) 的配体，通过 CRBN-CRL4 泛素连接酶对两种淋巴转录因子 IKZF1 和 IKZF3 进行选择性泛素化和降解。Lenalidomide hydrochloride (CC-5013 hydrochloride) 特别地抑制成熟 B 细胞淋巴瘤 (包括多发性骨髓瘤) 的生长，并诱导 T 细胞释放白细胞介素-2 (IL-2)。

研究领域：PROTAC

作用靶点：Ligands for E3 Ligase  |  Molecular Glues

In Vitro: Lenalidomide is potent in stimulating T cell proliferation and IFN-γ and IL-2 production. Lenalidomide has been shown to inhibit production of pro inflammatory cytokines TNF-α, IL-1, IL-6, IL-12 and elevate the production of anti-inflammatory cytokine IL-10 from human PBMCs. Lenalidomide downregulates the production of IL-6 directly and also by inhibiting multiple myeloma (MM) cells and bone marrow stromal cells (BMSC) interaction, which augments the apoptosis of myeloma cells. Dose-dependent interaction with the CRBN-DDB1 complex is observed with Thalidomide, Lenalidomide and Pomalidomide, with IC₅₀ values of ~30 μM, ~3 μM and ~3 μM, respectively, These reduced CRBN expression cells (U266-CRBN₆₀ and U266-CRBN₇₅) are less responsive than the parental cells to antiproliferative effects Lenalidomide across a dose-response range of 0.01 to 10 μM. Lenalidomide, a thalidomide analog, functions as a molecular glue between the human E3 ubiquitin ligase cereblon and CKIα is shown to induce the ubiquitination and degradation of this kinase, thus presumably killing leukemic cells by p53 activation.

In Vivo: The toxicity of Lenalidomide doses up to 15, 22.5, and 45 mg/kg via IV, IP, and PO routes of administration. Limited by solubility in our PBS dosing vehicle, these maximum achievable Lenalidomide doses are well tolerated with the exception of one mouse death (of four total dosed) at the 15 mg/kg IV dose. Notably, no other toxicities are observed in the study at IV doses of 15 mg/kg (n=3) or 10 mg/kg (n=45) or at any other dose level through IV, IP, and PO routes.

相关产品：Cyclosporin A  |  Lenalidomide  |  Pomalidomide  |  CC-885  |  Eragidomide  |  Iberdomide  |  Indisulam  |  3-Indoleacetic acid  |  Thalidomide  |  Mezigdomide  |  VH-298  |  E7820  |  VH032  |  BI-3802  |  Avadomide  |  TMX-4116  |  ALV2  |  Cemsidomide  |  Chloroquinoxaline sulfonamide  |  (S,R,S)-AHPC monohydrochloride  |  (S,S,S)-AHPC hydrochloride  |  HQ461  |  (S,R,S)-AHPC-Me hydrochloride  |  Golcadomide  |  Tasisulam  |  VH032-cyclopropane-F  |  Voclosporin  |  Lenalidomide-Br  |  NRX-252262  |  (R)-CR8 trihydrochloride

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds